<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04715828</url>
  </required_header>
  <id_info>
    <org_study_id>2020 PONS-REJRAJI</org_study_id>
    <nct_id>NCT04715828</nct_id>
  </id_info>
  <brief_title>Impact of Ionizing Treatment on the Nuclear Structure of Human Spermatozoa.</brief_title>
  <official_title>Impact of Ionizing Treatment on the Nuclear Structure of Human Spermatozoa.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agence de La Biom√©decine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Differentiated thyroid cancer is the third cause of cancer in young men of childbearing age.&#xD;
      Its treatment by irradiation with Radioactive Iodine 131 therapy (RAT) could alter&#xD;
      spermatogenesis and result in azoospermia and permanent infertility. A preventive gametes&#xD;
      cryopreservation was recommended before RAT, but without mentioning a period of teratogenic&#xD;
      risk transmissible to the offspring. To date, RAT impact on human sperm nucleus is poorly&#xD;
      known or even unknown, notably on telomere length.&#xD;
&#xD;
      Our objective is to define RAT effects on human sperm nucleus by in vitro irradiation&#xD;
      exposure of human spermatozoa to mimicking that of the gonads in the context of irradiation&#xD;
      with iodine131 used for thyroid cancer. We will analyze standard sperm parameters, major DNA&#xD;
      alterations and telomere length using molecular and cellular assays. Nucleus morphology and&#xD;
      chromatin organization will also be analyzed using 3D bio-imaging. This study will permit to&#xD;
      optimize the indications for the preservation of fertility.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our main objective is to measure the in vitro impact of irradiation treatment on sperm&#xD;
      nuclear quality such as DNA fragmentation and oxidation, chromatin condensation and&#xD;
      organisation, nucleus morphology and notably sperm telomere length (STL).&#xD;
&#xD;
      The secondary objectives are :&#xD;
&#xD;
        -  to measure RAT impact on sperm parameters (vitality, motility and morphology)&#xD;
&#xD;
        -  to measure the impact of cryopreservation on chromatin organisation and nucleus&#xD;
           morphology&#xD;
&#xD;
        -  to evaluate RAT impact on human sperm cells in comparison with cryopreservation&#xD;
&#xD;
        -  to evaluate the impact of different doses and types of irradiation on human sperm cells&#xD;
&#xD;
        -  to establish relations between potential alterations of standards sperm parameters&#xD;
           (vitality, motility and morphology) and nuclear sperm parameters (DNA fragmentation and&#xD;
           oxidation, chromatin condensation and organisation, nucleus morphology and STL.&#xD;
&#xD;
      Our final goal is to provide a significant improvement of men fertility diagnosis and&#xD;
      optimize our fertility preservation practices.&#xD;
&#xD;
      To this end, we will expose ejaculated human spermatozoa (n = 90) at different (low and&#xD;
      moderate) doses of gamma or X photons to mimic gonads irradiation. Absorbed doses by the&#xD;
      samples were calculated using the GATE Monte Carlo platform (version 8.2). Experiment&#xD;
      geometry settings were modelled as three dimension voxelized volumes inside the software by&#xD;
      assigning a shape, size, distance and density for all the volumes created. All measurements&#xD;
      will be made on surplus samples from men undergoing routine semen analysis at the Center for&#xD;
      Reproductive Medicine, after receiving their written informed consent. Semen samples are&#xD;
      collected and subdivided into 3 arms to analyse sperm quality after:&#xD;
&#xD;
        -  irradiation exposure (3 conditions);&#xD;
&#xD;
        -  a freezing- thawing cycle;&#xD;
&#xD;
        -  fresh state: negative control without treatment.&#xD;
&#xD;
      Before (fresh state) and after each treatment we will analyse:&#xD;
&#xD;
        -  standard semen parameters (vitality, motility and morphology) in accordance with WHO,&#xD;
           2010;&#xD;
&#xD;
        -  STL using Flow FISH, q-PCR and q-FISH;&#xD;
&#xD;
        -  chromatin condensation (chromomycin A3);&#xD;
&#xD;
        -  DNA oxidization (8-OHdG residues);&#xD;
&#xD;
        -  DNA fragmentation (TUNEL);&#xD;
&#xD;
        -  3D nucleus structure using 3D bio-imaging.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To measure in vitro the impact of an ionizing radiation treatment on sperm nuclear quality and in particular the size of telomeres.</measure>
    <time_frame>01/01/2018-01/01/2022</time_frame>
    <description>To achieve this goal, we will expose human sperm to an irradiation dose of I131 to mimic the irradiation of gonads and sperm. Reliquat of semen will be cryopreserved (control condition). After thawing, the same sample will be subdivised into 2 groups in order to analyze the sperm quality :&#xD;
After an irradiation dose of I131&#xD;
After a cryopreservation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To measure in vitro the impact of an irradiation dose of I131 on sperm nuclear quality, notably on STL.</measure>
    <time_frame>01/01/2018-01/01/2022</time_frame>
    <description>All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples will be collected and subdivided into 3 arms to analyse sperm quality after:&#xD;
irradiation exposure (3 conditions);&#xD;
a freezing- thawing cycle;&#xD;
fresh state: negative control without treatment.&#xD;
Before (fresh state) and after each treatment we will analyse:&#xD;
STL using Flow FISH, q-PCR and q-FISH;&#xD;
chromatin condensation (chromomycin A3);&#xD;
DNA oxidization (8-OHdG residues);&#xD;
DNA fragmentation (TUNEL);&#xD;
3D nucleus structure using 3D bio-imaging.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>to measure RAT impact on sperm parameters (vitality, motility and morphology)</measure>
    <time_frame>01/01/2018-01/01/2022</time_frame>
    <description>All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples will be collected and subdivided into 3 arms to analyse sperm quality after:&#xD;
irradiation exposure (3 conditions);&#xD;
a freezing- thawing cycle;&#xD;
fresh state: negative control without treatment.&#xD;
a freezing- thawing cycle;&#xD;
fresh state: negative control without treatment. Before (fresh state) and after each treatment we will analyse standard semen parameters (vitality, motility and morphology) in accordance with WHO, 2010;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To measure in vitro the impact of cryopreservation on sperm nuclear quality, notably on STL, chromatin organisation and nucleus morphology</measure>
    <time_frame>01/01/2018-01/01/2022</time_frame>
    <description>All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples will be collected and subdivided into 3 arms to analyse sperm quality after:&#xD;
irradiation exposure (3 conditions);&#xD;
a freezing- thawing cycle;&#xD;
fresh state: negative control without treatment.&#xD;
Before (fresh state) and after each treatment we will analyse:&#xD;
STL using Flow FISH, q-PCR and q-FISH;&#xD;
chromatin condensation (chromomycin A3);&#xD;
DNA oxidization (8-OHdG residues);&#xD;
DNA fragmentation (TUNEL);&#xD;
3D nucleus structure using 3D bio-imaging.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>to evaluate RAT impact on human sperm cells in comparison with cryopreservation</measure>
    <time_frame>01/01/2018-01/01/2022</time_frame>
    <description>We will compare effects induced by RAT and cryopreservation on each sperm sample. In order to limit the bias, for each irradiation treatment, a sample of sperm cells (cryopreserved control) will be treated under identical conditions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>to evaluate the impact of different doses and types of irradiation on human sperm cells</measure>
    <time_frame>01/01/2018-01/01/2022</time_frame>
    <description>All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples will be collected and subdivided into 3 arms to analyse sperm quality after:&#xD;
irradiation exposure (3 conditions);&#xD;
a freezing- thawing cycle;&#xD;
fresh state: negative control without treatment.&#xD;
Irradiation exposure will be realised under 3 conditions:&#xD;
acute and low irradiation : sperm sample will be placed on the scanner's processing table to be exposed for 1 to 2 seconds. Several dose levels will then be made in order to limit the value of 17 mGy.&#xD;
long and low irradiation: sperm sample will be exposed to gamma radiation by adding a solution of Tc99m for 3 hours.&#xD;
long and medium irradiation : sperm sample will be exposed to gamma radiation by adding a solution of I131 for 3 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>to establish relations between potential alterations of standards sperm parameters (vitality, motility and morphology) and nuclear sperm parameters (DNA fragmentation and oxidation, chromatin condensation and organisation, nucleus morphology and STL.</measure>
    <time_frame>01/01/2018-01/01/2022</time_frame>
    <description>We will correlate the effects induced by on vitality, motility and morphology and nuclear sperm parameters (DNA fragmentation and oxidation, chromatin condensation and organisation, nucleus morphology and STL.</description>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Sperm Preservation</condition>
  <condition>Irradiated Semen</condition>
  <arm_group>
    <arm_group_label>control arm &quot;fresh&quot;</arm_group_label>
    <description>Fresh semen treated without irradiation before cryopreservation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control arm &quot;cryopreserved&quot;</arm_group_label>
    <description>cryopreserved semen without irradiation (n=60)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>acute irradiation at low dose</arm_group_label>
    <description>Pelvis scanning : acute irradiation (1 or 2 second) using low dose (n=30),</description>
  </arm_group>
  <arm_group>
    <arm_group_label>long irradiation at low dose</arm_group_label>
    <description>Bone scintigraphy : long irradiation (3h) using low dose (n=30),</description>
  </arm_group>
  <arm_group>
    <arm_group_label>long irradiation at medium dose</arm_group_label>
    <description>Radioactive Iodine 131 therapy (RAT) applied for thyroid cancer : long irradiation (3h) using medium dose (n=60),</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cryopreserved semen</intervention_name>
    <description>sperm will be frozen in Cryosperm¬Æ cryoprotectant medium (Origio). The samples will be packaged in previously identified high security straws (Cryobiosystem). Slow freezing of the straws will be carried out using the Nanodigicool¬Æ programmable device (Cryobiosystem).</description>
    <arm_group_label>control arm &quot;cryopreserved&quot;</arm_group_label>
    <arm_group_label>control arm &quot;fresh&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acute and low irradiation</intervention_name>
    <description>sperm sample will be placed on the scanner's processing table to be exposed for 1 to 2 seconds. Several dose levels will then be made in order to limit the value of 17 mGy</description>
    <arm_group_label>acute irradiation at low dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Long and low irradiation</intervention_name>
    <description>sperm sample will be exposed to gamma radiation by adding a solution of Tc99m for 3 hours.</description>
    <arm_group_label>long irradiation at low dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Long and medium irradiation</intervention_name>
    <description>sperm sample will be exposed to gamma radiation by adding a solution of I131 for 3 hours</description>
    <arm_group_label>long irradiation at medium dose</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All measurements are made on surplus samples from men undergoing routine semen analysis at&#xD;
        the Center for Reproductive Medicine, after receiving their written informed consent&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Man less than 45 years&#xD;
&#xD;
          -  Man undergoing routine semen analysis at the Center for Reproductive Medicine,&#xD;
             accepting the research protocol and signing the associated consent will be included in&#xD;
             the protocol without distinction of physical criteria.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanae PONS-REJRAJI, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU de Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lise Laclautre, PharmD</last_name>
    <phone>04 73 75 49 63</phone>
    <phone_ext>34</phone_ext>
    <email>promo_interne_drci@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lise Laclautre, PharmD</last_name>
      <phone>04 73 75 49 62</phone>
      <phone_ext>33</phone_ext>
      <email>promo_interne_drci@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Hana√© PONS-REJRAJI, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florence BRUGNON, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sol√®ne VORILHON, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cyril BOUCHE, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aur√©lie VEGA, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe VAGO, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andre√Ø TCHIRKOV, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>C√©line PEBREL-RICHARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ga√´lle SALAUN, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lauren VERONESE, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laetitia GOUAS, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole GOUMY, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 15, 2021</study_first_submitted>
  <study_first_submitted_qc>January 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 20, 2021</study_first_posted>
  <last_update_submitted>January 15, 2021</last_update_submitted>
  <last_update_submitted_qc>January 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fertility Preservation</keyword>
  <keyword>Ionizing radiation</keyword>
  <keyword>Human sperm</keyword>
  <keyword>Thyroid Cancer</keyword>
  <keyword>Nuclear alterations</keyword>
  <keyword>Telomere length</keyword>
  <keyword>DNA Fragmentation and Oxidation</keyword>
  <keyword>Chromatin decondensation</keyword>
  <keyword>Conventional sperm parameters</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

